Browsing "1. Journal Papers" by Author : 755

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 17 to 31 of 31

This table browses all dspace content
Issue DateTitleJournal Title
2017Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls CANCER RESEARCH AND TREATMENT
2022Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer CANCER RESEARCH AND TREATMENT
2016Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy JOURNAL OF BREAST CANCER
2020Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and OlderBREAST CANCER RESEARCH AND TREATMENT
2018Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's PerspectiveCLINICAL BREAST CANCER
2016Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer PLOS ONE
2011Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast CancerONCOLOGY
2017Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results ANNALS OF SURGICAL TREATMENT AND RESEARCH
2023On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates BREAST CANCER RESEARCH
2020Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2021Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer FRONTIERS IN ONCOLOGY
2021Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary PerspectiveANNALS OF SURGERY
2019Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status ANNALS OF SURGICAL TREATMENT AND RESEARCH
2018Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer BMC CANCER
2016유전체 의학 시대를 맞이한 유전성 유방암-난소암 증후군 유전 검사의 임상적 함의: 임상의사가 바라본 전망 Journal of Breast Disease
1

Browse

Links